Steven Cohen Madrigal Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

$44.6 Billion
Q2 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 110,877 shares of MDGL stock, worth $49.1 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

110,877

Previous 65,860 68.35%

Holding current value

$49.1 Million

Previous $21.8 Million 53.82%

% of portfolio

0.08%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$267.56 - $340.8 $12 Million - $15.3 Million	45,017 Added 68.35%	110,877 $33.6 Million
Q1 2025 May 15, 2025	BUY	$272.79 - $355.88 $18 Million - $23.4 Million	65,860 New	65,860 $21.8 Million
Q2 2024 Aug 14, 2024	SELL	$193.33 - $291.99 $10.2 Million - $15.4 Million	-52,613 Reduced 56.23%	40,958 $11.5 Million
Q1 2024 May 15, 2024	BUY	$171.37 - $283.23 $16 Million - $26.5 Million	93,571 New	93,571 $25 Million
Q3 2023 Nov 14, 2023	BUY	$146.04 - $225.78 $25.3 Million - $39 Million	172,900 New	172,900 $25.3 Million
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $922,622 - $1.23 Million	3,993 New	3,993 $967,000
Q3 2022 Nov 14, 2022	BUY	$60.57 - $79.51 $1.39 Million - $1.82 Million	22,876 New	22,876 $1.49 Million
Q4 2021 Feb 14, 2022	SELL	$72.34 - $95.09 $2.18 Million - $2.86 Million	-30,100 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$78.35 - $105.02 $2.36 Million - $3.16 Million	30,100 New	30,100 $2.4 Million
Q2 2020 Aug 14, 2020	SELL	$60.13 - $125.71 $4.74 Million - $9.92 Million	-78,900 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$66.76 - $93.49 $5.27 Million - $7.38 Million	78,900 New	78,900 $5.27 Million
Q4 2019 Feb 14, 2020	SELL	$84.28 - $118.5 $2.57 Million - $3.62 Million	-30,521 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$84.4 - $106.53 $2.31 Million - $2.92 Million	-27,379 Reduced 47.29%	30,521 $2.63 Million
Q2 2019 Aug 14, 2019	BUY	$91.13 - $142.5 $3.38 Million - $5.29 Million	37,133 Added 178.81%	57,900 $6.07 Million
Q1 2019 May 15, 2019	SELL	$103.48 - $143.84 $3.34 Million - $4.64 Million	-32,233 Reduced 60.82%	20,767 $2.6 Million
Q4 2018 Feb 14, 2019	SELL	$94.77 - $215.54 $3.96 Million - $9.01 Million	-41,800 Reduced 44.09%	53,000 $5.97 Million
Q3 2018 Nov 14, 2018	BUY	$207.3 - $300.31 $19.7 Million - $28.5 Million	94,800 New	94,800 $20.3 Million
Q2 2018 Aug 14, 2018	SELL	$101.55 - $313.9 $4.05 Million - $12.5 Million	-39,900 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$93.35 - $149.04 $7.48 Million - $11.9 Million	-80,100 Reduced 66.75%	39,900 $4.66 Million
Q4 2017 Feb 14, 2018	BUY	$39.35 - $97.37 $4.72 Million - $11.7 Million	120,000	120,000 $11 Million

Others Institutions Holding MDGL

# of Institutions

356

Shares Held

23.2M

Call Options Held

738K

Put Options Held

473K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $7.58B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account